SE410603B - Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin - Google Patents

Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin

Info

Publication number
SE410603B
SE410603B SE7611467A SE7611467A SE410603B SE 410603 B SE410603 B SE 410603B SE 7611467 A SE7611467 A SE 7611467A SE 7611467 A SE7611467 A SE 7611467A SE 410603 B SE410603 B SE 410603B
Authority
SE
Sweden
Prior art keywords
methylergoline
carboxamido
cyano
dimethyl
procedure
Prior art date
Application number
SE7611467A
Other languages
English (en)
Other versions
SE7611467L (sv
Inventor
J A Clemens
E C Kornfeld
N J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7611467L publication Critical patent/SE7611467L/sv
Publication of SE410603B publication Critical patent/SE410603B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7611467A 1972-07-21 1976-10-15 Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin SE410603B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27390272A 1972-07-21 1972-07-21

Publications (2)

Publication Number Publication Date
SE7611467L SE7611467L (sv) 1976-10-15
SE410603B true SE410603B (sv) 1979-10-22

Family

ID=23045910

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7309781A SE393111B (sv) 1972-07-21 1973-07-12 Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE7611467A SE410603B (sv) 1972-07-21 1976-10-15 Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
SE7611466A SE410459B (sv) 1972-07-21 1976-10-15 Mellanforening till anvendning vid framstellning av en d-2-substituerad-6-metyl-8-substituerad ergolin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7309781A SE393111B (sv) 1972-07-21 1973-07-12 Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7611466A SE410459B (sv) 1972-07-21 1976-10-15 Mellanforening till anvendning vid framstellning av en d-2-substituerad-6-metyl-8-substituerad ergolin

Country Status (24)

Country Link
JP (2) JPS576431B2 (sv)
AR (3) AR206772A1 (sv)
AT (1) AT331425B (sv)
BE (1) BE802531A (sv)
BG (3) BG21411A3 (sv)
CA (1) CA1006159A (sv)
CH (5) CH578563A5 (sv)
CS (1) CS208164B2 (sv)
DD (1) DD107690A5 (sv)
DE (2) DE2365974A1 (sv)
DK (1) DK140986B (sv)
ES (5) ES417078A1 (sv)
FR (1) FR2193606B1 (sv)
GB (1) GB1423065A (sv)
HU (1) HU167274B (sv)
IE (1) IE37936B1 (sv)
IL (3) IL48288A (sv)
NL (1) NL7309969A (sv)
PH (1) PH11229A (sv)
RO (2) RO71305A (sv)
SE (3) SE393111B (sv)
SU (3) SU645581A3 (sv)
YU (1) YU36953B (sv)
ZA (1) ZA734627B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
JPH0596382U (ja) * 1992-05-28 1993-12-27 イビデン株式会社 ドアユニット

Also Published As

Publication number Publication date
DK140986C (sv) 1980-07-21
JPS5781487A (en) 1982-05-21
PH11229A (en) 1977-10-28
CH580625A5 (sv) 1976-10-15
ES442885A1 (es) 1977-04-16
ES417078A1 (es) 1976-05-01
RO71305A (ro) 1982-03-24
ES442886A1 (es) 1977-04-16
IL48288A0 (en) 1975-12-31
AR206772A1 (es) 1976-08-23
FR2193606A1 (sv) 1974-02-22
ES442887A1 (es) 1977-05-16
IL42730A0 (en) 1973-10-25
DE2335750C3 (de) 1978-10-19
CH578564A5 (sv) 1976-08-13
SU584780A3 (ru) 1977-12-15
HU167274B (sv) 1975-09-27
SE410459B (sv) 1979-10-15
DE2365974A1 (de) 1977-03-24
RO63792A (fr) 1978-12-15
YU194573A (en) 1982-06-18
SU575029A3 (ru) 1977-09-30
ZA734627B (en) 1974-06-26
DD107690A5 (sv) 1974-08-12
AT331425B (de) 1976-08-25
CS208164B2 (en) 1981-08-31
SU645581A3 (ru) 1979-01-30
SE7611466L (sv) 1976-10-15
CA1006159A (en) 1977-03-01
BG21411A3 (sv) 1976-05-20
JPS5813541B2 (ja) 1983-03-14
DE2335750B2 (de) 1978-02-23
BE802531A (fr) 1974-01-21
CH580626A5 (sv) 1976-10-15
ES446789A1 (es) 1977-06-01
GB1423065A (en) 1976-01-28
JPS4985099A (sv) 1974-08-15
AR210072A1 (es) 1977-06-30
JPS576431B2 (sv) 1982-02-04
YU36953B (en) 1984-08-31
SE7611467L (sv) 1976-10-15
AR206887A1 (es) 1976-08-31
NL7309969A (sv) 1974-01-23
CH581135A5 (sv) 1976-10-29
CH578563A5 (sv) 1976-08-13
SE393111B (sv) 1977-05-02
FR2193606B1 (sv) 1977-07-15
IL48288A (en) 1976-06-30
ATA643473A (de) 1975-11-15
DK140986B (da) 1979-12-17
IL42730A (en) 1976-06-30
BG21410A3 (bg) 1976-05-20
AU5792673A (en) 1975-01-16
IE37936L (en) 1974-01-21
DE2335750A1 (de) 1974-02-14
IE37936B1 (en) 1977-11-23
BG22400A3 (bg) 1977-02-20

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE423540B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE395460B (sv) Forfarande for framstellning av 2beta,16beta-dipiperidino-5alfa-androstaner
SE7611467L (sv) Forfarande for framstellning av d-2,6-dimetyl-8-cyano(karboxamido)metylergolin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
FI52735C (sv) Förfarande för framställning av nya pregnadien-21-syraderivat.
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
SE405853B (sv) Forfarande for framstellning av 2-kinoxalinkarboxamid-1,4-dioxider
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer
SE408643B (sv) Forfarande for framstellning av morfantridiner